Peri-procedural use of rivaroxaban in elective percutaneous coronary intervention to treat stable coronary artery disease The X-PLORER trial

MLA

Vranckx, Pascal, et al. “Peri-Procedural Use of Rivaroxaban in Elective Percutaneous Coronary Intervention to Treat Stable Coronary Artery Disease The X-PLORER Trial.” Vranckx , P , Leebeek , F , Adal , K , Koolen , J , Stammen , F , Herman , JPR , de Winter , RJ , Hof , AWJ , Backx , B , Lindeboom , W , Kim , SY , Kirsch , B , van Eickels , M , Misselwitz , F & Verheugt , FWA 2015 , ’ Peri-Procedural Use of Rivaroxaban in Elective Percutaneous Coronary Intervention to Treat Stable Coronary Artery Disease The X-PLORER Trial ’ , Thrombosis and Haemostasis , Vol. 114 , No. 2 , Pp. 258-267 , 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1313619740&authtype=sso&custid=ns315887.

APA

Vranckx, P., Leebeek, F., Adal, K., Koolen, J., Stammen, F., Herman, J., de Winter, R., Hof, A., Backx, B., Lindeboom, W., Kim, S., Kirsch, B., van Eickels, M., Misselwitz, F., & Verheugt, F. (2015). Peri-procedural use of rivaroxaban in elective percutaneous coronary intervention to treat stable coronary artery disease The X-PLORER trial. Vranckx , P , Leebeek , F , Adal , K , Koolen , J , Stammen , F , Herman , JPR , de Winter , RJ , Hof , AWJ , Backx , B , Lindeboom , W , Kim , SY , Kirsch , B , van Eickels , M , Misselwitz , F & Verheugt , FWA 2015 , ’ Peri-Procedural Use of Rivaroxaban in Elective Percutaneous Coronary Intervention to Treat Stable Coronary Artery Disease The X-PLORER Trial ’ , Thrombosis and Haemostasis , Vol. 114 , No. 2 , Pp. 258-267 .

Chicago

Vranckx, Pascal, Frank Leebeek, Kedir Adal, J Koolen, F Stammen, Jpr Herman, Rj de Winter, et al. 2015. “Peri-Procedural Use of Rivaroxaban in Elective Percutaneous Coronary Intervention to Treat Stable Coronary Artery Disease The X-PLORER Trial.” Vranckx , P , Leebeek , F , Adal , K , Koolen , J , Stammen , F , Herman , JPR , de Winter , RJ , Hof , AWJ , Backx , B , Lindeboom , W , Kim , SY , Kirsch , B , van Eickels , M , Misselwitz , F & Verheugt , FWA 2015 , ’ Peri-Procedural Use of Rivaroxaban in Elective Percutaneous Coronary Intervention to Treat Stable Coronary Artery Disease The X-PLORER Trial ’ , Thrombosis and Haemostasis , Vol. 114 , No. 2 , Pp. 258-267 . http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1313619740&authtype=sso&custid=ns315887.